Cytarabine, daunorubicin and etoposide (ADE) chemotherapy in acute myeloid leukemia (AML) patients >= 60 years (CALGB 9720)
   Google Scholar   
Citation:
Blood vol 110 (11) 94A-94A
Year:
2007
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Parents:
None
Children:
87  
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                           
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8461, CALGB-9720
Phases:
3, N/A
Keywords: